WaveMan · Form 4
OrbiMed Genesis GP LLC insider trades
> Search tickers & screens ⌘K
LIVE

OrbiMed Genesis GP LLC insider trades

OrbiMed Genesis GP LLC has filed 27 Form 4s with the SEC that we hold, for Disc Medicine, Inc. (IRON) (Director), Janux Therapeutics, Inc. (JANX) (Director), Edgewise Therapeutics, Inc. (EWTX) (Director, 10% owner) and KNTE (Director, 10% owner), among 16 companies in all. Across all of them we count 22 purchases worth $65.3M and 41 sales worth $94.1M reported on Form 4. In the last 12 months: 2 purchases ($12.5M) and 0 sales ($0). The largest single trade was a sale of 1,195,683 shares of ALPN worth $21.9M, dated 2023-12-28. The first filing on our record is dated 2021-10-14 and the latest 2026-06-09.

Disc Medicine, Inc. (IRON)

Director · 4 filings · 14 purchases and sales
Trade dateCodeSharesValue as filedFiled
2023-12-12S, sale reported on Form 414,400$866.3K2023-12-14
2023-12-12S, sale reported on Form 49,300$559.5K2023-12-14
2023-12-12S, sale reported on Form 43,600$216.6K2023-12-14
2023-12-13S, sale reported on Form 456,200$3.3M2023-12-14
2023-12-13S, sale reported on Form 414,100$825.7K2023-12-14
2023-12-13S, sale reported on Form 436,400$2.1M2023-12-14
2023-12-14S, sale reported on Form 4147,600$8.4M2023-12-15
2023-12-14S, sale reported on Form 457,100$3.2M2023-12-15
2023-12-14S, sale reported on Form 4228,500$13.0M2023-12-15
2023-12-14S, sale reported on Form 4100$5.8K2023-12-14
2023-12-18S, sale reported on Form 41,724$102.1K2023-12-20
2024-06-17P, purchase reported on Form 428,404$1.0M2024-06-20
2024-06-17P, purchase reported on Form 410,986$395.5K2024-06-20
2024-06-17P, purchase reported on Form 443,944$1.6M2024-06-20

Janux Therapeutics, Inc. (JANX)

Director · 3 filings · 6 purchases and sales
Trade dateCodeSharesValue as filedFiled
2021-12-16S, sale reported on Form 4356,800$6.8M2021-12-17
2021-12-16S, sale reported on Form 436,500$696.1K2021-12-17
2021-12-21S, sale reported on Form 4108,300$2.1M2021-12-23
2021-12-21S, sale reported on Form 411,100$210.9K2021-12-23
2021-12-29S, sale reported on Form 436,700$745.0K2021-12-30
2021-12-29S, sale reported on Form 43,700$75.1K2021-12-30

Edgewise Therapeutics, Inc. (EWTX)

Director, 10% owner · 2 filings · 3 purchases and sales
Trade dateCodeSharesValue as filedFiled
2022-09-16P, purchase reported on Form 4484,496$5.0M2022-09-16
2025-04-03P, purchase reported on Form 4124,193$2.5M2025-04-04
2025-04-03P, purchase reported on Form 4372,578$7.5M2025-04-04

KNTE

Director, 10% owner · 2 filings · 4 purchases and sales
Trade dateCodeSharesValue as filedFiled
2022-02-11P, purchase reported on Form 4156,000$1.6M2022-02-15
2022-02-14P, purchase reported on Form 420,700$206.6K2022-02-15
2022-02-14P, purchase reported on Form 410,000$98.9K2022-02-15
2022-02-15P, purchase reported on Form 49,000$89.6K2022-02-15

Keros Therapeutics, Inc. (KROS)

Director · 2 filings · 2 purchases and sales
Trade dateCodeSharesValue as filedFiled
2024-08-13S, sale reported on Form 429,400$1.3M2024-08-15
2024-08-13S, sale reported on Form 4220,600$9.7M2024-08-15

PMV Pharmaceuticals, Inc. (PMVP)

10% owner · 2 filings · 4 purchases and sales
Trade dateCodeSharesValue as filedFiled
2022-03-29S, sale reported on Form 4365,000$7.9M2022-03-31
2022-03-30S, sale reported on Form 475,000$1.7M2022-03-31
2022-03-31S, sale reported on Form 434,500$730.4K2022-03-31
2023-11-22S, sale reported on Form 487,786$195.8K2023-11-24

TERN

Director, 10% owner · 2 filings · 7 purchases and sales
Trade dateCodeSharesValue as filedFiled
2022-12-23P, purchase reported on Form 4137,931$1,000.0K2022-12-28
2024-07-15S, sale reported on Form 46,142$61.4K2024-07-17
2024-07-15S, sale reported on Form 45,401$54.0K2024-07-17
2024-07-15S, sale reported on Form 439,433$394.3K2024-07-17
2024-07-16S, sale reported on Form 4623$6.2K2024-07-17
2024-07-16S, sale reported on Form 44,009$40.1K2024-07-17
2024-07-16S, sale reported on Form 4556$5.6K2024-07-17

THRX

Director, 10% owner · 2 filings · 3 purchases and sales
Trade dateCodeSharesValue as filedFiled
2021-10-12P, purchase reported on Form 4562,500$9.0M2021-10-14
2021-10-12P, purchase reported on Form 462,500$1.0M2021-10-14
2022-11-07P, purchase reported on Form 4192,000$1.0M2022-11-09

ALPN

Director · 1 filing · 6 purchases and sales
Trade dateCodeSharesValue as filedFiled
2023-12-27S, sale reported on Form 418,922$377.7K2023-12-29
2023-12-27S, sale reported on Form 4162,576$3.2M2023-12-29
2023-12-28S, sale reported on Form 426,872$532.6K2023-12-29
2023-12-28S, sale reported on Form 4139,166$2.5M2023-12-29
2023-12-28S, sale reported on Form 41,195,683$21.9M2023-12-29
2023-12-28S, sale reported on Form 43,128$62.0K2023-12-29

Compass Therapeutics, Inc. (CMPX)

Director, 10% owner · 1 filing · 2 purchases and sales
Trade dateCodeSharesValue as filedFiled
2021-11-04P, purchase reported on Form 41,785,715$6.3M2021-11-08
2021-11-04P, purchase reported on Form 43,571,428$12.5M2021-11-08

Damora Therapeutics, Inc. (GLTO)

10% owner · 1 filing · 6 purchases and sales
Trade dateCodeSharesValue as filedFiled
2023-04-05S, sale reported on Form 425,220$55.0K2023-04-07
2023-04-05S, sale reported on Form 463,058$137.5K2023-04-07
2023-04-05S, sale reported on Form 44,687$10.2K2023-04-07
2023-04-06S, sale reported on Form 46,558$13.1K2023-04-07
2023-04-06S, sale reported on Form 42,620$5.2K2023-04-07
2023-04-06S, sale reported on Form 4487$9742023-04-07

Enliven Therapeutics, Inc. (ELVN)

Director, 10% owner · 1 filing · 0 purchases and sales

No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.

ImageneBio, Inc. (IMA)

Director · 1 filing · 0 purchases and sales

No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.

MBX Biosciences, Inc. (MBX)

Director, 10% owner · 1 filing · 4 purchases and sales
Trade dateCodeSharesValue as filedFiled
2025-02-14P, purchase reported on Form 417,962$177.8K2025-02-19
2025-02-14P, purchase reported on Form 429,540$291.0K2025-02-19
2025-02-18P, purchase reported on Form 494,100$1.0M2025-02-19
2025-02-18P, purchase reported on Form 449,070$531.9K2025-02-19

Prelude Therapeutics Inc (PRLD)

Director, 10% owner · 1 filing · 2 purchases and sales
Trade dateCodeSharesValue as filedFiled
2026-04-21P, purchase reported on Form 41,689,189$7.5M2026-04-23
2026-04-21P, purchase reported on Form 41,126,126$5.0M2026-04-23

Shattuck Labs, Inc. (STTK)

Director · 1 filing · 0 purchases and sales

No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.

Source

Counted from the Form 4 filings this reporting owner (SEC CIK 1808744) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.

Source: U.S. Securities and Exchange Commission (EDGAR) and other official government data · Updated 2026-10-12 · For informational purposes only, not investment advice.
Privacy · Terms